Liv 52

composition of Liv-52 tablet: Capparis spinosa-65 mg, Cichorium intybus-65 mg, Solanum nigrum-32 mg, Cassia occidentalis-16 mg, Terminalia arjuna-32 mg, Achillea millefolium-16 mg, Tamarix gallica-16 mg, Mandur bhasma-33 mg

Also Known As:

Networked: 19 relevant articles (4 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Cekic, Arif Burak: 1 article (01/2020)
2.	Cimen, Orhan: 1 article (01/2020)
3.	Eken, Hüseyin: 1 article (01/2020)
4.	Keskin Cimen, Ferda: 1 article (01/2020)
5.	Kurnaz, Eray: 1 article (01/2020)
6.	Kurt, Nezahat: 1 article (01/2020)
7.	Mammadov, Renad: 1 article (01/2020)
8.	Ozbek Bilgin, Asli: 1 article (01/2020)
9.	Pehlivanoglu, Kamil: 1 article (01/2020)
10.	Suleyman, Bahadir: 1 article (01/2020)

Related Diseases

1.	Liver Diseases (Liver Disease) 10/01/2005 - "Liv 52, an Ayurvedic hepatoprotective agent, is not useful in the management of alcohol-induced liver disease. " 01/01/2003 - "Our results suggest that Liv.52 may not be useful in the management of patients with alcohol induced liver disease." 11/01/2004 - "LIV.52 has been withdrawn from the market because of deleterious effects in patients with liver disease. " 12/17/1997 - "In the literature are reports on preparation LIV 52 which is a mixture of substances of plant origin and improves the subjective complaints of patients as well as the objective condition of patients with liver disease. " 05/01/2005 - "Neither vitamin E nor Liv 52 had a useful effect in alcohol-related liver disease. "
2.	Liver Cirrhosis (Hepatic Cirrhosis) 09/01/2005 - "In the present study, the efficacy of herbal medicine Liv-52 (consisting of Mandur basma, Tamarix gallica and herbal extracts of Capparis spinosa, Cichorium intybus, Solanum nigrum, Terminalia arjuna and Achillea millefolium) on liver cirrhosis outcomes was compared with the placebo for 6 months in 36 cirrhotic patients referred to Tehran Hepatic Center. " 09/01/2011 - "Significant efficacy has been seen with silymarin, glycyrrhizin and Liv-52 in treatment of hepatitis, alcoholic liver disease and liver cirrhosis."
3.	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/01/2003 - "We conducted a controlled trial to assess the efficacy of Liv.52 in patients with alcoholic liver disease. " 01/01/2003 - "Liv.52 in alcoholic liver disease: a prospective, controlled trial." 01/01/2003 - "Liv.52, a hepatoprotective agent of herbal origin, is used empirically for the treatment of alcoholic liver disease in Sri Lanka. "
4.	Hepatitis 04/01/1978 - "Leprous hepatitis: clinico-pathological study and therapeutic efficacy of Liv 52."
5.	Non-alcoholic Fatty Liver Disease 04/01/2016 - "The objective of the present study is to evaluate the effect of the extract of a well-known hepatospecific polyherbal formulation, Liv.52, in an experimental model of high-fat diet (HFD)-induced nonalcoholic steatohepatitis (NASH) in rats. "

Related Drugs and Biologics

1.	Glycyrrhizic Acid (Glycyrrhizin)
2.	Silymarin
3.	PPAR gamma
4.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
5.	Enzymes
6.	Carbon Tetrachloride (Tetrachloromethane)
7.	Ethanol (Ethyl Alcohol)
8.	shosaiko-to (TJ9)
9.	complement H100 (CH(100))
10.	Vitamin E